| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6109674 | Journal of Hepatology | 2009 | 8 Pages |
Abstract
When known and treated BCS is well controlled, pregnancy should not be contraindicated as maternal outcome, and fetal outcome beyond gestation week 20, are good. The risk-benefit ratio of anticoagulant therapy needs to be further clarified. Patients should be fully informed of the persistent risks of such pregnancies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Pierre-Emmanuel Rautou, Bernhard Angermayr, Juan-Carlos Garcia-Pagan, Rami Moucari, Markus Peck-Radosavljevic, Sebastian Raffa, Jacques Bernuau, Bertrand Condat, Michel Levardon, Carine Yver, Guillaume Ducarme, Dominique Luton, Marie-Hélène Denninger,